Entera Bio Ltd.
ENTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001638097
No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Entera Bio Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +2 vs. Q2 2024
- Shares held
- 5.32M
- +30.0K (+0.6%) vs. Q2 2024
- Total value
- $10.1M
- +$367.0K (+3.8%) vs. Q2 2024
- New holders
- 3
- 3 more added
- Sold out
- 1
- 3 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $19.0M |
| Q1 2026 | 26 | $8.68M |
| Q4 2025 | 22 | $18.1M |
| Q3 2025 | 22 | $17.7M |
| Q2 2025 | 19 | $19.4M |
| Q1 2025 | 18 | $17.4M |
| Q4 2024 | 14 | $15.9M |
| Q3 2024 | 17 | $10.1M |
| Q2 2024 | 15 | $9.75M |
| Q1 2024 | 15 | $7.11M |
| Q4 2023 | 10 | $2.44M |
| Q3 2023 | 12 | $1.87M |
| Q2 2023 | 12 | $2.17M |
| Q1 2023 | 9 | $3.28M |
| Q4 2022 | 12 | $415.9K |
| Q3 2022 | 9 | $4.85M |
| Q2 2022 | 10 | $6.54M |
| Q1 2022 | 12 | $14.2M |
| Q4 2021 | 12 | $15.9M |
| Q3 2021 | 14 | $26.7M |
| Q2 2021 | 14 | $30.6M |
| Q1 2021 | 8 | $7.57M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Entera Bio Ltd.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 3,881,879 | $7.38M | 3.56% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 648,600 | $1.23M | 0.01% | −23,158−3.4% | Reduced |
| Parkman Healthcare Partners LLC | 411,076 | $781.0K | 0.10% | +9,558+2.4% | Added |
| UBS Group AG | 142,747 | $271.2K | 0.00% | −24,876−14.8% | Reduced |
| Renaissance Technologies LLC | 61,200 | $116.3K | 0.00% | +3,600+6.3% | Added |
| Signature Estate & Investment Advisors LLC | 47,328 | $89.9K | 0.00% | +47,328 | New |
| Susquehanna International Group, LLP | 20,658 | $39.3K | 0.00% | −8,198−28.4% | Reduced |
| Citadel Advisors LLC | 20,553 | $39.1K | 0.00% | +20,553 | New |
| Geode Capital Management, LLC | 17,597 | $33.4K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 16,777 | $30.2K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 13,000 | $24.7K | 0.00% | 00.0% | Unchanged |
| CIBC World Markets Inc. | 12,500 | $24.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 11,830 | $22.0K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 9,000 | $17.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8,430 | $16.0K | 0.00% | +5,430+181.0% | Added |
| Group One Trading, L.P. | 51 | $97 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $4 | 0.00% | +2 | New |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −260−100.0% | Sold out |